<SEC-DOCUMENT>0001193125-23-188876.txt : 20230718
<SEC-HEADER>0001193125-23-188876.hdr.sgml : 20230718
<ACCEPTANCE-DATETIME>20230718162528
ACCESSION NUMBER:		0001193125-23-188876
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230718
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Cost Associated with Exit or Disposal Activities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230718
DATE AS OF CHANGE:		20230718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		231094517

	BUSINESS ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d838523d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amrn="http://www.amarincorp.com/20230718" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-07-18_to_2023-07-18">AMARIN CORP PLC\UK</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityTaxIdentificationNumber" name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-07-18_to_2023-07-18">00-0000000</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2023-07-18_to_2023-07-18" name="dei:EntityCentralIndexKey" contextRef="duration_2023-07-18_to_2023-07-18">0000897448</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2023-07-18_to_2023-07-18" name="dei:AmendmentFlag" contextRef="duration_2023-07-18_to_2023-07-18">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="amrn-20230718.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-07-18_to_2023-07-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000897448</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-18</xbrli:startDate> <xbrli:endDate>2023-07-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-07-18_to_2023-07-18">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt:date-monthname-day-year-en">July 18, 2023</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Amarin Corporation plc</span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen">England and Wales</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityFileNumber">0-21392</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style=" -sec-ix-hidden:Hidden_dei_EntityTaxIdentificationNumber">Not applicable</span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityAddressAddressLine1">Iconic Offices, The Greenway</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityAddressAddressLine2">Block C Ardilaun Court</ix:nonNumeric>,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityAddressAddressLine3">112 - 114 St Stephens Green</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityAddressCityOrTown">Dublin</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityAddressPostalZipCode">2</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen">Ireland</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold">Not applicable</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:CountryRegion">353</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:CityAreaCode">1</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:LocalPhoneNumber">6699 020</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:Security12bTitle">American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1) Ordinary Share of Amarin Corporation plc</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:TradingSymbol">AMRN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">Nasdaq Stock Market LLC</ix:nonNumeric></td></tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;2.02</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;18, 2023, Amarin Corporation plc (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Amarin</span></span>&#8221; or the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#8221;) issued a press release announcing its preliminary financial results for the three months ended June&#160;30, 2023 (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Press Release</span></span>&#8221;). These financial results are based on preliminary information and management estimates for the three months ended June&#160;30, 2023, are not a comprehensive statement of Amarin&#8217;s financial results, and are subject to completion of Amarin&#8217;s financial closing procedures. A copy of the Press Release is furnished herewith as Exhibit 99.1.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The information in this report furnished pursuant to Item 2.02 shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;</span><span style="font-weight:bold"><span style="font-style:italic">Exchange Act</span></span><span style="font-style:italic">&#8221;), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended (the &#8220;</span><span style="font-weight:bold"><span style="font-style:italic">Securities Act</span></span><span style="font-style:italic">&#8221;), if such subsequent filing specifically references the information furnished pursuant to Item 2.02 of this report. </span></p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;2.05</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Costs Associated with Exit or Disposal Activities.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;18, 2023, as described in the Press Release, Amarin announced that it was implementing a new organizational restructuring program (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">ORP</span></span>&#8221;), resulting in the elimination and consolidation of certain roles across the organization, both in the United States and abroad, representing a reduction of the total Amarin employee base by approximately 30% from current levels. Management, with oversight and guidance of the Amarin board of directors (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Board</span></span>&#8221;), determined to implement the ORP following a review of Amarin&#8217;s business and to better position the organization for a new strategic focus. The Company expects these actions will reduce operating costs by approximately $40&#160;million annually.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the ORP, the Board promoted several members of the Company&#8217;s management team, including Tom Reilly, the Company&#8217;s Senior Vice President, Chief Financial Officer and Secretary (and principal financial and accounting officer), who was promoted to Executive Vice President, Chief Financial Officer&#160;&amp; Head of Global HR (and principal financial and accounting officer), with an increased base salary amount of $560,000.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amarin estimates that it will incur approximately $10&#160;million in charges related to the ORP, substantially all of which are cash <span style="white-space:nowrap">expenditures&#160;for&#160;one-time&#160;termination&#160;benefits</span> and associated costs. Amarin expects to record the charges in the second quarter of 2023 and to make substantially all of the related payments by December&#160;31, 2023.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;18, 2023, Amarin appointed Patrick Holt to serve as the Company&#8217;s President and Chief Executive Officer (and principal executive officer), and as a member of the Board, effective July&#160;18, 2023.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Holt most recently served as president of Cordis, Cardinal Health&#8217;s global interventional cardiovascular business and as member of Cardinal Health Inc&#8217;s global operating committee. In this role, Mr.&#160;Holt led a successful turnaround that included a return to revenue growth, a refocused R&amp;D strategy, as well as sustained enhancements in operational effectiveness delivering margin expansion. Subsequently, he led the transaction process which culminated in the sale of Cordis to Hellman&#160;&amp; Friedman in 2021 for an enterprise value in excess of $1&#160;billion. He also previously served as president of Cardinal Health in Asia-Pacific. Prior to his time at Cardinal Health, he served in a variety of senior executive positions across biopharmaceuticals and vaccines at Allergan and Merck. Mr.&#160;Holt is an independent <span style="white-space:nowrap">non-executive</span> director and audit committee member of Hugel, Inc., a publicly listed biopharmaceutical company and global leader in medical aesthetics. He earned a bachelor&#8217;s degree in biochemistry and chemistry from Monash University, Australia and is a graduate of Harvard Business School.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon Mr.&#160;Holt&#8217;s start date, Aaron Berg, who has been serving as the Company&#8217;s Interim President and Chief Executive Officer, will resume his role as Amarin&#8217;s Executive Vice President, President U.S. In light of Mr.&#160;Berg&#8217;s excellence and effectiveness in the interim role, the Board has awarded Mr.&#160;Berg a <span style="white-space:nowrap">one-time</span> cash bonus of $150,000.</p></div></div> <p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company plans to file a subsequent Form <span style="white-space:nowrap">8-K</span> with details on Mr.&#160;Holt&#8217;s compensation arrangements and other information required by Item 5.02 of Form <span style="white-space:nowrap">8-K.</span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on July&#160;18, 2023, as a complement to the ORP, Amarin announced the implementation of a retention program for certain employees at various levels and among various organizations, which includes a cash component, payable in two tranches, with the first tranche payable in February 2024 (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">1</span></span><span style="font-weight:bold"><span style="font-style:italic"><sup style="font-size:75%; vertical-align:top">st</sup></span></span><span style="font-weight:bold"><span style="font-style:italic"> Installment</span></span>&#8221;) and the second tranche payable in February 2025 (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">2</span></span><span style="font-weight:bold"><span style="font-style:italic"><sup style="font-size:75%; vertical-align:top">nd</sup></span></span><span style="font-weight:bold"><span style="font-style:italic"> Installment</span></span>&#8221;), subject to the employee&#8217;s continued service with the Company. The eligible employees were also granted an option award, effective as of July&#160;19, 2023, with an exercise price equal to the closing price of the American depositary shares representing the Company&#8217;s ordinary shares, as reported on the Nasdaq Global Market on such date, which vests as to 50% on January&#160;1, 2024 and as to the remaining 50% on January&#160;1, 2025. If an eligible employee is terminated without cause or resigns for good reason prior to the payment or vesting dates, as applicable, the cash awards (to the extent not yet paid) will become payable and the vesting on any unvested options shall accelerate, subject to the employee signing a customary release. Mr.&#160;Berg, Mr.&#160;Reilly and Steven Ketchum, Ph.D., Amarin&#8217;s President R&amp;D and Chief Scientific Officer, were among the employees granted the retention awards and were granted the awards as follows:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">
<tr>
<td style="width:64%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom">1<sup style="font-size:75%; vertical-align:top">st</sup>&#160;Installment</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom">2<sup style="font-size:75%; vertical-align:top">nd</sup>&#160;Installment</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom">Option&#160;Shares</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aaron Berg</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">142,326</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">142,326</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">404,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tom Reilly</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">136,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">136,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">404,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Ketchum</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">161,460</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">161,460</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="text-align:right;white-space:nowrap;vertical-align:bottom">404,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;18, 2023, Amarin issued a second press release announcing the appointment of Mr.&#160;Holt. Amarin&#8217;s press release is furnished herewith as Exhibit 99.2 to this report.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The information in this report furnished pursuant to Item 7.01 shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange, or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act if such subsequent filing specifically references the information furnished pursuant to Item 7.01 of this report. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This report contains forward-looking information about Amarin within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Any statements contained herein which do not describe historical facts, including statements related to the Company&#8217;s preliminary financial results, the ORP, the Chief Executive Officer roles, retention matters and business plans and are forward-looking statements, which involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. These forward-looking statements are not promises or guarantees. Among the factors that could cause actual results to differ materially from those described herein include the Company&#8217;s ability to generate sufficient revenues and cash from sales of Vascepa and to retain sufficient talent to successfully execute on the Company&#8217;s plans, including following implementation of the ORP, the risk that the ORP will not produce the expected benefits and cost savings, as well as those risks and uncertainties described in Amarin&#8217;s Annual Reports on Form <span style="white-space:nowrap">10-K,</span> Quarterly Reports on Form <span style="white-space:nowrap">10-Q,</span> Current Reports on Form <span style="white-space:nowrap">8-K</span> and other filings with the U.S. Securities and Exchange Commission from time to time, including its most recent Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarter ended March&#160;31, 2023 and its upcoming Form <span style="white-space:nowrap">10-Q</span> for the quarter ended June&#160;30, 2023. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information contained in this Current Report, whether as a result of new information, future events or circumstances or otherwise.</p></div></div> <p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap">Description</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d838523dex991.htm">Press Release, dated July&#160;18, 2023 (furnished herewith) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d838523dex992.htm">Press Release, dated July&#160;18, 2023 (furnished herewith) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">* &#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160; *</p></div></div> <p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0">
<tr>
<td style="width:45%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: July&#160;18, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">Amarin Corporation plc</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tom Reilly</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Tom Reilly</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr></table></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d838523dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amarin Implements Organizational Restructuring to Strengthen the Company While Driving Patient </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Access to VASCEPA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>/VAZKEPA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
Globally </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Focus on Gaining Access for European Patients in Remaining Geographies and Strategic Use of Commercial Resources
&#151; </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Maximizes Cash Flow Opportunity Through Streamlined Model in U.S. &#151; </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Company Expects Restructuring to Drive Annual Cost Savings of Approximately $40 Million &#151; </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Announces Preliminary Earnings Results for Second Quarter 2023 &#151; </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Company to Host Conference Call Today at 5:00 p.m. EDT &#151; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DUBLIN, Ireland and BRIDGEWATER, N.J., July</B><B></B><B>&nbsp;18, 2023 </B>&#151; Amarin Corporation plc (NASDAQ: AMRN) today announced that it has
initiated an organizational restructuring program to <FONT STYLE="white-space:nowrap">right-size</FONT> and strengthen the Company to enhance shareholder value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Over the last several months, the new Amarin Board of Directors and senior management team have conducted a comprehensive review of the business. VASCEPA<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>/VAZKEPA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is supported by a wealth of clinical data and backed by strong science that can benefit patients around the world. Amarin
continues to generate revenue in the U.S. and maintains a strong cash position. However, the restructuring announced today reflects the need for a thoughtful and significant change in strategy given the Company&#146;s size, resources and challenging
operating environment. The Company expects these actions will reduce operating costs by approximately $40&nbsp;million annually. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin&#146;s refocused
strategic priorities and restructuring plan focuses on three core areas: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Maximizing U.S. Cash Flow Through Streamlined Model: </B>Amarin will maintain VASCEPA as a cost-effective
option to generics while implementing a reduction in force of all U.S. sales force positions and approximately 30% of <FONT STYLE="white-space:nowrap">non-sales</FONT> roles. Amarin will retain its managed care and trade organization to support
these efforts. The Company will continue to explore innovative approaches to driving revenue as well as the timing of an authorized generic version of VASCEPA to maintain its leadership position in the icosapent ethyl (IPE) market.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>European Redesign: </B>Amarin will redesign its commercial infrastructure in Europe to better align with
pricing and reimbursement status, commercial potential and progress to date, as well as streamline certain cross-geographic functions and better leverage learnings across countries. In addition, Amarin will continue to advance its pricing and
reimbursement activities to drive access in remaining geographies, including those where progress has been delayed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Expanding Upon International Partnerships: </B>Amarin will work on generating revenue from its partnerships in
key international markets, including Canada, MENA, China and Australia / New Zealand, and will continue to explore additional partnerships. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;A thorough review confirmed our belief in the inherent value of Amarin and the need for change when it
comes to managing the business for value creation,&#148; said Odysseas Kostas, M.D., and Chairman of the Board. &#147;The actions we have taken since joining the Board reflect our ongoing efforts to turn around the company. The organizational
restructuring and our new CEO hire announced today will support those strategic efforts. Our focus continues to be bringing VASCEPA/VAZKEPA to high-risk patients and generating value for Amarin shareholders as we execute against this strategy.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are grateful for the efforts and commitments of our impacted colleagues who have worked tirelessly to advance our mission in the U.S. and
globally,&#148; said Aaron Berg, Amarin&#146;s Interim President and CEO. &#147;These are difficult, but necessary decisions to best position Amarin for the future and ensure we can give millions of patients globally the opportunity to access
VASCEPA/VAZKEPA. We maintain strong conviction around VASCEPA/VAZKEPA, which is supported by a wealth of clinical data and backed by strong science, particularly the results of the <FONT STYLE="white-space:nowrap">REDUCE-IT</FONT> trial and its
impact on cardiovascular outcomes, which clearly underscore the product&#146;s value in addressing a significant unmet need to reduce major adverse cardiovascular events in high-risk patients.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preliminary Q2 2023 Earnings Results </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with
today&#146;s announcement, Amarin also announced preliminary unaudited financial results for the second quarter of 2023, including product revenue of approximately $65&nbsp;million compared to $85&nbsp;million in the first quarter of 2023. For the
quarter, the Company had positive cash flow of $9&nbsp;million, which includes a $5&nbsp;million milestone payment following the recent VHTG regulatory approval in China. The second quarter end cash position was $313&nbsp;million versus
$304&nbsp;million at the end of the first quarter. Further details will be discussed on today&#146;s conference call. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;In the second quarter, we
maintained our U.S. prescription volume for VASCEPA and our overall cash position is positive,&#148; Mr.&nbsp;Berg said. &#147;However, our product revenue was impacted by increasing net pricing pressure and other inter-quarter variability in the
U.S. and we also saw slower than expected revenue materialization and pricing and reimbursement access in Europe. As a result, we are taking decisive and significant actions to realign our business, which will maximize our strong cash position while
putting us on the right path to enhance shareholder value.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call and Webcast Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin will host a conference call on July&nbsp;18, 2023, at 5:00 p.m. EDT to discuss this announcement and the Company&#146;s preliminary financial results.
The conference call can be accessed on the investor relations section of the Company&#146;s website at www.amarincorp.com, or via telephone by dialing <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">888-506-0062</FONT></FONT>
within the United States, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">973-528-0011</FONT></FONT> from outside the United States, and referencing conference ID 897730. A replay of the call will be made available for a period of
one week following the conference call. To listen to a replay of the call, dial <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-481-4010</FONT></FONT> from within the United States and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">919-882-2331</FONT></FONT> from outside of the United States, and reference conference ID 48709. A replay of the call will also be available through the Company&#146;s website shortly after the call. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In light of the call scheduled for today, Amarin will release its full second quarter 2023 financial results on August&nbsp;2, 2023, but will not hold a
conference call at that time. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Amarin </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. Amarin is committed to increasing the scientific
understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in
Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements, within the meaning of U.S. securities laws, including, but not limited to, expectations regarding
Amarin&#146;s financial performance, metrics, and initiatives, including its 2023 revenues, operating expenses, supply purchases, negotiations and settlements, product prescriptions and managed care coverage, continued savings from cost-cutting
initiatives that is currently exceeding initial targets, and Amarin&#146;s overall ability to continue to deliver stable revenues and cash position from its U.S. business; beliefs about the timing and outcome of international commercial
partnerships, regulatory filings, reviews, recommendations, approvals, and related reimbursement decisions and commercial launches of VASCEPA/VAZKEPA outside of the U.S.; beliefs that Amarin&#146;s current resources are sufficient to fund projected
operations; and beliefs about the overall world-wide market potential and success of VASCEPA/VAZKEPA generally. These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. A list and description
of these risks, uncertainties and other risks associated with an investment in Amarin can be found in Amarin&#146;s filings with the U.S. Securities and Exchange Commission, including Amarin&#146;s most recent quarterly report on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31, 2023. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Amarin
undertakes no obligation to update or revise the information contained in its forward-looking statements, whether as a result of new information, future events or circumstances or otherwise. Amarin&#146;s forward-looking statements do not reflect
the potential impact of significant transactions the company may enter into, such as mergers, acquisitions, dispositions, joint ventures or any material agreements that Amarin may enter into, amend or terminate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Availability of Other Information About Amarin </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>Investors and others should note that Amarin communicates with its investors and the public using the company website (<B>www.amarincorp.com</B>), the
investor relations website <FONT STYLE="white-space:nowrap">(amarincorp.gcs-web.com),</FONT> including but not limited to investor presentations and investor FAQs, U.S. Securities and Exchange Commission filings, press releases, public conference
calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media, and others interested in Amarin to review the information that is
posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin&#146;s investor relations website and may include social media channels. The contents of
Amarin&#146;s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amarin Contact Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Inquiries: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jordan Zwick </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin Corporation plc </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IR@amarincorp.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Media Inquiries: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Marmur </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin Corporation plc </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PR@amarincorp.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d838523dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amarin Appoints Patrick Holt as President and Chief Executive Officer </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DUBLIN, Ireland and BRIDGEWATER, N.J., July</B><B></B><B>&nbsp;18, 2023</B> &#150; Amarin Corporation plc (NASDAQ: AMRN) today announced that the
Company&#146;s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. Aaron Berg, who served as Interim President and CEO since April 2023, will remain
with the Company in a senior leadership role. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Holt brings more than 25 years of leadership in the life sciences industry and significant
international operating experience. He most recently served as president of Cordis, Cardinal Health&#146;s global interventional cardiovascular business where he led a turnaround of the business, followed by a transaction process which led to its
successful sale. Mr.&nbsp;Holt previously held a variety of senior executive positions across biopharmaceuticals and vaccines at Allergan and Merck. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are excited to welcome Pat as our new CEO,&#148; said Odysseas Kostas, M.D., the Chairman of the Board. &#147;Pat&#146;s international and
cardiovascular business experience and track record of turnaround success are exactly what the Company needs at this critical time. The Board looks forward to working with Pat to continue to put Amarin on the best path to maximizing shareholder
value.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Holt said, &#147;The science at Amarin is compelling and aligned to a significant unmet need, and VASCEPA<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>/VAZKEPA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> maintains meaningful untapped value given its clinical profile and proven cardiovascular risk reduction and outcomes. Decisive
action is needed to realize Amarin&#146;s full potential, and alongside the entire Amarin team, I am committed to realizing the opportunities inherent in the business to maximize value for patients, physicians, payors and shareholders. I look
forward to working with the Board and leadership team as we evaluate and execute on all opportunities to enhance value.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Kostas concluded,
&#147;On behalf of the Board, I want to thank Aaron for stepping up to lead when he did, working tirelessly over the last few months toward strengthening the Company&#146;s global operations. We look forward to him continuing to contribute in an
important way at Amarin.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Patrick Holt </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patrick Holt most recently served as president of Cordis, Cardinal Health&#146;s global interventional cardiovascular business and as member of Cardinal Health
Inc&#146;s global operating committee. In this role, Mr.&nbsp;Holt led a successful turnaround that included a return to revenue growth, a refocused R&amp;D strategy, as well as sustained enhancements in operational effectiveness delivering margin
expansion. Subsequently, he led the transaction process which culminated in the sale of Cordis to Hellman&nbsp;&amp; Friedman in 2021 for an enterprise value in excess of $1&nbsp;billion. He also previously served as president of Cardinal Health in
Asia-Pacific. Prior to his time at Cardinal Health, he served in a variety of senior executive positions across biopharmaceuticals and vaccines at Allergan and Merck. Mr.&nbsp;Holt is an independent
<FONT STYLE="white-space:nowrap">non-executive</FONT> director and audit committee member of Hugel, Inc., a publicly listed biopharmaceutical company and global leader in medical aesthetics. He earned a bachelor&#146;s degree in biochemistry and
chemistry from Monash University, Australia and is a graduate of Harvard Business School. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Amarin </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. Amarin is committed to increasing the scientific
understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in
Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements, within the meaning of U.S. securities laws, including, but not limited to, expectations regarding
Amarin&#146;s financial performance, metrics, and initiatives, including its 2023 revenues, operating expenses, supply purchases, negotiations and settlements, product prescriptions and managed care coverage, continued savings from cost-cutting
initiatives that is currently exceeding initial targets, and Amarin&#146;s overall ability to continue to deliver stable revenues and cash position from its U.S. business; beliefs about the timing and outcome of international commercial
partnerships, regulatory filings, reviews, recommendations, approvals, and related reimbursement decisions and commercial launches of VASCEPA/VAZKEPA outside of the U.S.; beliefs that Amarin&#146;s current resources are sufficient to fund projected
operations; and beliefs about the overall world-wide market potential and success of VASCEPA/VAZKEPA generally. These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. A list and description
of these risks, uncertainties and other risks associated with an investment in Amarin can be found in Amarin&#146;s filings with the U.S. Securities and Exchange Commission, including Amarin&#146;s most recent quarterly report on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended March&nbsp;31, 2023. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Amarin
undertakes no obligation to update or revise the information contained in its forward-looking statements, whether as a result of new information, future events or circumstances or otherwise. Amarin&#146;s forward-looking statements do not reflect
the potential impact of significant transactions the company may enter into, such as mergers, acquisitions, dispositions, joint ventures or any material agreements that Amarin may enter into, amend or terminate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Availability of Other Information About Amarin </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>Investors and others should note that Amarin communicates with its investors and the public using the company website (www.amarincorp.com), the investor
relations website <FONT STYLE="white-space:nowrap">(amarincorp.gcs-web.com),</FONT> including but not limited to investor presentations and investor FAQs, U.S. Securities and Exchange Commission filings, press releases, public conference calls and
webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media, and others interested in Amarin to review the information that is posted on
these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin&#146;s investor relations website and may include social media channels. The contents of Amarin&#146;s
website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amarin Contact Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor Inquiries: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jordan Zwick </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin Corporation plc </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IR@amarincorp.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Media Inquiries: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Marmur </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amarin Corporation plc </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PR@amarincorp.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>amrn-20230718.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 71.2.1 -->
<!-- Creation date: 7/18/2023 12:42:26 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:amrn="http://www.amarincorp.com/20230718"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:us-types="http://fasb.org/us-types/2022"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.amarincorp.com/20230718"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amrn-20230718_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amrn-20230718_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>amrn-20230718_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 71.2.1 -->
<!-- Creation date: 7/18/2023 12:42:26 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Country Region</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Country Region</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>amrn-20230718_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 71.2.1 -->
<!-- Creation date: 7/18/2023 12:42:26 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amrn-20230718.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="26.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.071" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.171" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CountryRegion" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="32.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="32.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139750399047600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 18,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMARIN CORP PLC\UK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-21392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Iconic Offices, The Greenway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Block C Ardilaun Court<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">112 - 114 St Stephens Green<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6699 020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1) Ordinary Share of Amarin Corporation plc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMRN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000897448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d838523d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amrn-20230718.xsd" xlink:type="simple"/>
    <context id="duration_2023-07-18_to_2023-07-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000897448</identifier>
        </entity>
        <period>
            <startDate>2023-07-18</startDate>
            <endDate>2023-07-18</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityRegistrantName">AMARIN CORP PLC\UK</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityTaxIdentificationNumber">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityCentralIndexKey_duration_2023-07-18_to_2023-07-18">0000897448</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_AmendmentFlag_duration_2023-07-18_to_2023-07-18">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2023-07-18_to_2023-07-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-07-18_to_2023-07-18">2023-07-18</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-07-18_to_2023-07-18">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-07-18_to_2023-07-18">0-21392</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-07-18_to_2023-07-18">Iconic Offices, The Greenway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-07-18_to_2023-07-18">Block C Ardilaun Court</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2023-07-18_to_2023-07-18">112 - 114 St Stephens Green</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-07-18_to_2023-07-18">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-07-18_to_2023-07-18">2</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2023-07-18_to_2023-07-18">IE</dei:EntityAddressCountry>
    <dei:CountryRegion contextRef="duration_2023-07-18_to_2023-07-18">353</dei:CountryRegion>
    <dei:CityAreaCode contextRef="duration_2023-07-18_to_2023-07-18">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-07-18_to_2023-07-18">6699 020</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-07-18_to_2023-07-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-07-18_to_2023-07-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-07-18_to_2023-07-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-07-18_to_2023-07-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-07-18_to_2023-07-18">American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1) Ordinary Share of Amarin Corporation plc</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-07-18_to_2023-07-18">AMRN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-07-18_to_2023-07-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-07-18_to_2023-07-18">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MBCI8RX,K3>XPH,H_*%[XWPNQ=9 #"Q)<X.(2\S%:>07%:WJ>.QXL?0\/$"Y
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    "  M@_)6!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "V#\E:]!SW%
M[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( "V#\E:97)PC$ 8  )PG   3              "  <T!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ +8/R5GJ@()G(!   Q!(
M !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( "V#\E:?H!OPL0(  .(,   -              "  0P-  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ +8/R5I>*NQS     $P(   L
M         ( !Z \  %]R96QS+RYR96QS4$L! A0#%     @ +8/R5APX9>H_
M 0  / (   \              ( !T1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( "V#\E8D'INBK0   /@!   :              "  3T2  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "V#\E9ED'F2&0$
M ,\#   3              "  2(3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  &P4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d838523d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d838523d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d838523d8k.htm">d838523d8k.htm</File>
    <File>amrn-20230718.xsd</File>
    <File>amrn-20230718_lab.xml</File>
    <File>amrn-20230718_pre.xml</File>
    <File>d838523dex991.htm</File>
    <File>d838523dex992.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d838523d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d838523d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amrn-20230718_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amrn-20230718_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "amrn-20230718.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "amrn",
   "nsuri": "http://www.amarincorp.com/20230718",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d838523d8k.htm",
      "contextRef": "duration_2023-07-18_to_2023-07-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d838523d8k.htm",
      "contextRef": "duration_2023-07-18_to_2023-07-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-188876-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-188876-xbrl.zip
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M@ZQ&" G5;\J@I*T!;:#0(I@GJBV>N)-'ZJ]99:=H^C>=Y)G_ 5!+ P04
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MS@:G_DS@7)X<?6N?7IV>7++#LV-V\OO1Y\.S7T_ 'G[]>GIY>7I^]B08F\N
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M(T1(_$BA['1K<XH2)0?S69UR$H>:& 0@47,X]5AP/#O6R=;YAM?B@+H,*%,
M&$\WB;M(IT+Q!K;'! )"5E173J=(MPFK=+, $Y' ;^$W8)_"[$#K!^4B\>43
MD:#@H*/"V.F:K2Q(^E$/ZQ=J>GX2E^<S(,, K FJ6CRB(8.9IM>I7?9!RM%M
MV99H%//Z$,9+4*<S!<E+W$Y*EN3=3F0Y>YB13]MK_%89;4\^*%F_Y9+U<\-7
MG9[)7WV(C>90S<S$<G?Z:',LN<!Y2@I69)FS-'E)?HMUMM)$*U4:.=<]23&2
M-4/K"$;9Y1&MI1DH4%7)@WSZS)2=1^%\)((5)1(!!E%%W0*!+$66J!5N%7DE
M8 :,RWS8IFD-KJ5[D!__271TC&D00,7F,A.1C8<.EQ::;=_$4X+P]UOOIM=V
M&CS:BH?C%SL^#0;0V7A;38"$GU&#0.F'+#OQ +ZWEHGOYDOB&^_(>0%\E\=/
M<A,QRRDX3 ;&E&H%=P!L:2H23NO:)#1X_SV)),H$]59HYT7WL-P0'3$,(*RJ
MO!T+)3G9QIQRV4V42Y)\!$]3>^B_@Q</8( B!8?/@9V5-,C\<8$K0_>S,G1C
MR] G:L['G1N5E)K;%TC%:7<G.W,Y>E>%[!*KK@P9GM')KO6MK.*Y$9ALYV29
MMNKO2(OR$)G8[;5LE8<+)=V>M!B XD, 9[^S!7Z0+08=1S^ZI4D6T1WRJ1A<
M<8X5GE2G:8#Y;/%*3RF?86*7=*^+5B(K=C;CHFD/" ONRZ(CNR3).DZD4XFN
M>!ZCLC+2B,HH1H"<(9?^NO4$.R#@@TRP$[E/EJ&CAQ&+0_P#HGQH(QY;E@&!
MC0@P$!4S&9CA]NQ!# 2\8 *1F*ZDJ5ITZ7+!MCT(L$G\"*-G]IN(O'X\ />S
M7SVNEL?=U<PI30+JS F^]*2[,#'G!9-,D*W*0VM2$;&43RRA0R?.26_F1R7/
MC#MUNN<ZCE?0[Y>[>G%G\U']?MMIO]^]"=%"J]Y6\95Y?G\MTZZLOW .> N-
M)@N,GWP+^ @-UH=2,V6U%7:8-1[I)5FX"]9VL8V_-D0U'^G>_,<AZGR8G>'9
M%KA'[7A5?81['>Y=]RB/7'&9!#"MX)4](.:/.E7*IPX0AV)0#$DKR1\7BTO3
M]%5ZJ/,D_I@9?<\B\<]3WLXQ%.5%IG1+S]1!F\WR1G/[22 M2U;><+&*A9^
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MB[S3OE_K*'\$/R#F# [^'U!+ P04    "  M@_)6874KJ:X3   G0P  $0
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M:@IMA"D9JK'U,0Q(S)6,BAGM-P!2TU@1RD*R!,8RN++/0<LIS,4$FCV0K2V
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MM1W;3E6WQCSNSC+'<[[<$M@LIKHF2F=P]T=ANF5.#8B(;J0%2ME#\7-P6Q@
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MH:6"5,;@BR'T.UT-MO<8I"7'"]]%$QS;(RN;:DFK1L)^=W]A-17PL]EPV9"
M0SO+(/QS+#EWCJJ&7'':>V8S]'T1MOJE15AOH2^!V2[.LM;&-X(\<[7=;]9#
MS>[[-@AL[FQM_2@#_;4XX;^0!]@)OG\3Q0<#+(Q(3$6'&]^&>>A#_YKF(4CN
MI[D.KNX+Q0^RV!W?=_S&1QR=_[,9Y[Y]#?DM0\_WTR+8_!51^KC,_T^5>':7
M$F\!.KCJZ> WO,G_@XS_ %!+ P04    "  M@_)6ZOBR<1X.  "I*0  $0
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M."YX<V102P$"% ,4    "  M@_)6,?J12,0&  #\2P  %0
M@ $S P  86UR;BTR,#(S,#<Q.%]L86(N>&UL4$L! A0#%     @ +8/R5C2W
M[H[(!   =2\  !4              ( !*@H  &%M<FXM,C R,S W,3A?<')E
M+GAM;%!+ 0(4 Q0    ( "V#\E: )""__1L  /^K   .              "
M 24/  !D.#,X-3(S9#AK+FAT;5!+ 0(4 Q0    ( "V#\E9A=2NIKA,  "=#
M   1              "  4XK  !D.#,X-3(S9&5X.3DQ+FAT;5!+ 0(4 Q0
M   ( "V#\E;J^+)Q'@X  *DI   1              "  2L_  !D.#,X-3(S
@9&5X.3DR+FAT;5!+!08     !@ & '\!  !X30     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
